📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ContraFect

1.1 - Company Overview

ContraFect Logo

ContraFect

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology research focused on monoclonal antibodies to treat life-threatening infectious diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ContraFect

Appili Therapeutics Logo

Appili Therapeutics

HQ: Canada Website
  • Description: Provider of anti-infective pharmaceutical development solutions, addressing unmet medical needs with improvements to established therapies and new classes of anti-infectives. Pipeline includes ATI-1701, a live-attenuated tularemia vaccine candidate; ATI-1801, a topical antiparasitic for cutaneous leishmaniasis; and LIKMEZ (ATI-1501), an oral taste-masked metronidazole suspension.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Appili Therapeutics company profile →
Daktari Diagnostics Logo

Daktari Diagnostics

HQ: United States Website
  • Description: Provider of diagnostic medical products for clinicians and patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Daktari Diagnostics company profile →
Iomai Logo

Iomai

HQ: United States Website
  • Description: Provider of vaccines and immune system stimulants delivered via transcutaneous immunization (TCI), a novel needle-free technology that taps antigen-presenting cells in the outer layers of the skin to generate an enhanced immune response.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iomai company profile →
Friz Biochem Logo

Friz Biochem

HQ: Germany Website
  • Description: Provider of advanced electronic biochips and offerings integrating the complete workflow of molecular diagnostics; privately held, founded in October 2004 and based in Neuried near Munich.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Friz Biochem company profile →
Ondine Biomedical Logo

Ondine Biomedical

HQ: Canada Website
  • Description: Provider of non-antibiotic, anti-infective therapies for bacterial, viral, and fungal infections, including Steriwave nasal decolonization that eradicates pathogens in minutes (MRSA, SARS-CoV-2), Photodisinfection using a photosensitive agent and non-thermal laser light to destroy pathogens without resistance, and an Expanded Access Program for investigational medicines prior to regulatory approval.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ondine Biomedical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ContraFect

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ContraFect

2.2 - Growth funds investing in similar companies to ContraFect

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ContraFect

4.2 - Public trading comparable groups for ContraFect

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ContraFect

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ContraFect

What does ContraFect do?

ContraFect is a provider of biotechnology research focused on monoclonal antibodies to treat life-threatening infectious diseases.

Who are ContraFect's competitors?

ContraFect's competitors and similar companies include Appili Therapeutics, Daktari Diagnostics, Iomai, Friz Biochem, and Ondine Biomedical.

Where is ContraFect headquartered?

ContraFect is headquartered in United States.

How many employees does ContraFect have?

ContraFect has 1,000 employees 🔒.

When was ContraFect founded?

ContraFect was founded in 2010 🔒.

What sector and industry vertical is ContraFect in?

ContraFect is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ContraFect

Who are the top strategic acquirers in ContraFect's sector and industry

Top strategic M&A buyers and acquirers in ContraFect's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ContraFect?

Top strategic M&A buyers groups and sectors for ContraFect include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ContraFect's sector and industry vertical

Which are the top PE firms investing in ContraFect's sector and industry vertical?

Top PE firms investing in ContraFect's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ContraFect's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ContraFect's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ContraFect's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ContraFect include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ContraFect's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ContraFect?

The key public trading comparables and valuation benchmarks for ContraFect include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ContraFect for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ContraFect with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ContraFect's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ContraFect with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ContraFect's' sector and industry vertical?

Access recent funding rounds and capital raises in ContraFect's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ContraFect